SP110

protein-coding

SP110 nuclear body protein, the group of PHD finger proteins|Minor histocompatibility antigens|Bromodomain containing

Gene summary

The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]

Previous symbols:
  • IFI41
  • IFI75

MANE transcript

NM_080424.4

Inheritance

AR

ClinVar variants

P:46U:257B:147

Top phenotype

Hepatic venoocclusive disease with immunodeficiency

gnomAD constraint

pLI —, LoF o/e 0.69

Max pathogenic AF

—

Genomic locus

chr2:230,165,186-230,225,729

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~60.5 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

hepatic veno-occlusive disease-immunodeficiency syndromeDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009338

Submitter: ClinGen

SP110 was first reported in relation to autosomal recessive hepatic veno-occlusive disease-immunodeficiency syndrome (VODI) in 2006 (Rosicioli et al., PMID: 16648851). VODI is characterized by bacterial infections (including Pneumocystis jirovecii, cytomegalovirus, enterovirus, or mucocutaneous candidiasis), hepatomegaly or hepatic failure, liver biopsy results consistent with sinusoidal obstruction syndrome, hypogammaglobulinemia, low intracellular cytokine production, and usually T-cell immunodeficiency with normal circulating T and B cell counts. Some patients displayed a complex neurological phenotype, however the association with SP110 is not fully understood (PMID: 23448538). The mechanism of pathogenicity appears to be homozygous loss of function. The curation of SP110 related to autosomal recessive VODI includes both case-level and experimental evidence. Seven variants (missense, frameshift, and nonsense) reported in seven probands in four publications (PMIDs: 16648851, 22621957, 23448538, 32395362) are included in this curation. The heterozygous parents of probands were all unaffected. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by its enhanced expression in lymphoid tissue (PMID: 16127175), disruption of which is observed by flow cytometry of patient T cell blasts (PMID: 28825155). Additionally, functional alteration is reported in patient cells (PMID: 22621957), such that there is an impairment of B cells to produce IgM, IgG, and IgA. The impaired survival and activation of B cells in vitro most likely explains the hypogammaglobulinemia that is typical of patients with VODI. In summary, there is definitive evidence supporting the relationship between SP110 and autosomal recessive hepatic veno-occlusive disease-immunodeficiency syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.

hepatic veno-occlusive disease-immunodeficiency syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009338

Submitter: Labcorp Genetics (formerly Invitae)

hepatic veno-occlusive disease-immunodeficiency syndromeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0009338

Submitter: Ambry Genetics

hepatic veno-occlusive disease-immunodeficiency syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009338

Submitter: Orphanet

hepatic veno-occlusive disease-immunodeficiency syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0009338

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Hepatic venoocclusive disease with immunodeficiencyAR

Manifestation: Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Neurologic

Intervention: Allergy/Immunology/Infectious

Rationale: Mortality is high if the condition is unrecognized; interventions include intravenous immunoglobulin and infectious prophylaxis (Pneumocystis jerovici)

Refs: 16648851; 17510920; 22621957; 22982295Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SP110 variants in ClinVar

6 Conditions Cataloged
Hepatic veno-occlusive disease-immunodeficiency syndromeTotal: 482
Inborn genetic diseasesTotal: 113
not specifiedTotal: 40
not providedTotal: 32
SP110-related disorderTotal: 19
Mycobacterium tuberculosis, susceptibility toTotal: 16

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_080424.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
116
clinvar
3
clinvar
125
missense
1
clinvar
237
clinvar
24
clinvar
3
clinvar
265
nonsense
4
clinvar
10
clinvar
2
clinvar
1
clinvar
17
start loss
1
clinvar
1
frameshift
16
clinvar
5
clinvar
3
clinvar
24
splice donor/acceptor (+/-2bp)
10
clinvar
8
clinvar
18
Total21252571416450

Highest pathogenic variant AF is 0.000114628165

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 49 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_080424.4RefSeqNP_536349.318MANE Select
ENST00000258381.11EnsemblENSP00000258381.618MANE Select
NM_001185015.2RefSeqNP_001171944.115Standard
NM_001378442.1RefSeqNP_001365371.119Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • regulation of transcription by RNA polymerase II
  • viral process

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA binding
  • metal ion binding

Cellular Component

  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000258381
Coding exons
18
Length
58436
Individuals with no LoFs
125659
Homozygous LoFs
0
Heterozygous LoFs
89
Defined
125748
p
0.000354
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.3353553730.9510.00002084695
Missense (PolyPhen)2423.9361.0027232
Synonymous-0.1211411391.010.000008631307
Loss of Function1.832840.60.6890.00000221493

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000250.00025rare
Latino/Admixed American0.000170.00017rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish0.0000920.000092rare
European (Non-Finnish)0.000220.00022rare
South Asian0.00160.0016notable
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcription factor. May be a nuclear hormone receptor coactivator. Enhances transcription of genes with retinoic acid response elements (RARE).;
Disease
DISEASE: Hepatic venoocclusive disease with immunodeficiency (VODI) [MIM:235550]: Autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B-cell immunodeficiency, absent lymph node germinal centers, and absent tissue plasma cells. {ECO:0000269|PubMed:16648851}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.496
RVIS EVS
0.54
RVIS percentile EVS
81.1

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.682

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.